Dheeraj Aggarwal, CFO, Venus Remedies is especially ecstatic about bagging the marketing rights for Meropenem in Gulf, Saudi Arabia as the company would be the first generic player there.
Venus Remedies entered OTC (over-the-counter) category with Ezenus. Dheeraj Aggarwal, CFO, Venus Remedies says that Ezenus is our first OTC product which is a stress reliever. It works for reducing anti-toxicants in the body.
Dheeraj Aggarwal, CFO, Venus Remedies, speaking to CNBC-TV18 on the occasion of the company's first ever over-the-counter (OTC) stress reliving drug launch, said that it is a unique product with no competition.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.